BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28279399)

  • 21. Loss of melanocytes in hypopigmented mycosis fungoides: a study of 18 patients.
    Furlan FC; de Paula Pereira BA; da Silva LF; Sanches JA
    J Cutan Pathol; 2014 Feb; 41(2):101-7. PubMed ID: 24219812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Narrow-band ultraviolet B phototherapy for mycosis fungoides in children.
    Koh MJ; Chong WS
    Clin Exp Dermatol; 2014 Jun; 39(4):474-8. PubMed ID: 24825139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PUVA-induced pityriasis lichenoides chronica-like papular lesions in patients with mycosis fungoides: a clinical, histopathological and immunohistochemical study.
    Youssef R; Abdel-Halim MRE; Abdel Halim DM; Fawzy MM; Hussein MF; Elmasry MF; Sayed SS; Abo Eid NM
    Arch Dermatol Res; 2019 Nov; 311(9):673-678. PubMed ID: 31300833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric mycosis fungoides in Singapore: a series of 46 children.
    Heng YK; Koh MJ; Giam YC; Tang MB; Chong WS; Tan SH
    Pediatr Dermatol; 2014; 31(4):477-82. PubMed ID: 24890628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
    Herrmann JJ; Roenigk HH; Hurria A; Kuzel TM; Samuelson E; Rademaker AW; Rosen ST
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):234-42. PubMed ID: 7622650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypopigmented mycosis fungoides].
    Robert C; Bahlouli Z; Chemaly P; Flageul B; Blanchet-Bardon C; Dubertret L
    Ann Dermatol Venereol; 1995; 122(10):704-6. PubMed ID: 8687060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of stage Ia and Ib mycosis fungoides with psoralen UVA monotherapy: an observational study in tertiary hospitals in the Canary Islands.
    Hernández Z; Peñate Y; Hernández-Machín B; Pérez-Méndez L; Suárez-Hernández J; Hernández J; Fernández-de-Misa R
    Int J Dermatol; 2014 Nov; 53(11):1417-22. PubMed ID: 24697305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
    Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
    Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annular hypopigmented mycosis fungoides: a novel ringed variant.
    Uhlenhake EE; Mehregan DM
    J Cutan Pathol; 2012 May; 39(5):535-9. PubMed ID: 22515225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides.
    Khopkar U; Doshi BR; Dongre AM; Gujral S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):167-73. PubMed ID: 21393946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folliculotropic mycosis fungoides in a pediatric patient with response to psoralen-ultraviolet A phototherapy.
    Boix-Vilanova J; Corral-Magaña O; Martin-Santiago A; Escalas J
    Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):54-56. PubMed ID: 30007081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
    Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
    Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides.
    Delfau-Larue MH; Dalac S; Lepage E; Petrella T; Wechsler J; Farcet JP; Bagot M
    Blood; 1998 Nov; 92(9):3376-80. PubMed ID: 9787176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypopigmented interface T-cell dyscrasia: a form of cutaneous T-cell dyscrasia distinct from hypopigmented mycosis fungoides.
    Magro CM; Hagen JW; Crowson AN; Liu YC; Mihm M; Drucker NM; Yassin AH
    J Dermatol; 2014 Jul; 41(7):609-17. PubMed ID: 24806661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical variants of mycosis fungoides in a cohort.
    Domínguez-Gómez MA; Reyes-Salcedo CA; Morales-Sánchez MA; Jurado-Santa CF
    Gac Med Mex; 2021; 157(1):41-46. PubMed ID: 34125823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Juvenile-onset hypopigmented mycosis fungoides mimicking vitiligo.
    Ngo JT; Trotter MJ; Haber RM
    J Cutan Med Surg; 2009; 13(4):230-3. PubMed ID: 19706233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real-life experience from a single tertiary center.
    Doğan PE; Akay BN; Vural S; Arı C; Yılmaz TE; Şanlı H
    Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):428-434. PubMed ID: 36967646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profile and outcome of childhood mycosis fungoides in Singapore.
    Tan E; Tay YK; Giam YC
    Pediatr Dermatol; 2000; 17(5):352-6. PubMed ID: 11085660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood mycosis fungoides: a report of 20 cases from Turkey.
    Yazganoglu KD; Topkarci Z; Buyukbabani N; Baykal C
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):295-300. PubMed ID: 22176010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycosis fungoides in young patients: clinical characteristics and outcome.
    Crowley JJ; Nikko A; Varghese A; Hoppe RT; Kim YH
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):696-701. PubMed ID: 9591813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.